|
Chronic Pain Modulation of Mesolimbic Dopamine Signaling for Natural and Opiate Rewards |
1F31DA056200-01 |
|
NIDA |
2022 |
|
Increasing the health equity and population-level impact of a digital therapeutic for smokers with psychiatric illness |
1K02DA054304-01A1 |
|
NIDA |
2022 |
|
A Preconception Health Intervention to Reduce Substance Exposed Pregnancies among Incarcerated Women |
1K23DA053433-01A1 |
|
NIDA |
2022 |
|
Neurocognitive Impairments Resulting from Adolescent Prescription Opioid Use Disorder: Longitudinal Impact, Neural Mechanisms, and Comorbidities |
1K99DA056288-01 |
|
NIDA |
2022 |
|
Mechanisms of prenatal opioid exposure on brain and behavior |
1R01DA050871-01A1 |
|
NIDA |
2022 |
|
Role of disability and pain in opioid overdose: mechanism and risk mitigation |
1R01DA053243-01A1 |
|
NIDA |
2022 |
|
Impact of Medicare Part D opioid safety policies on disabled beneficiaries before and during the COVID-19 pandemic |
1R01DA055131-01 |
|
NIDA |
2022 |
|
Improving MOUD Access, Opioid-Related Outcomes and Equity Among Medicare Beneficiaries with Disability |
1R01DA057568-01 |
|
NIDA |
2022 |
|
Neurocognitive implications of cannabidiol (CBD) while aging with HIV |
1R03DA057146-01 |
|
NIDA |
2022 |
|
Social determinants of substance use disorder treatment outcomes in a vulnerable population |
1R21DA055229-01 |
|
NIDA |
2022 |